JO3810B1 - صيغ التستوستيرون الشحمية المساندة - Google Patents

صيغ التستوستيرون الشحمية المساندة

Info

Publication number
JO3810B1
JO3810B1 JOP/2014/0322A JOP20140322A JO3810B1 JO 3810 B1 JO3810 B1 JO 3810B1 JO P20140322 A JOP20140322 A JO P20140322A JO 3810 B1 JO3810 B1 JO 3810B1
Authority
JO
Jordan
Prior art keywords
testosterone
disclosed
proliposomal
testosterone formulations
formulations
Prior art date
Application number
JOP/2014/0322A
Other languages
English (en)
Inventor
Ramachandran Thirucote
Guru V Betageri
Veeran Gowda Kadajji
Original Assignee
Tesorx Pharma Llc
Univ Western Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tesorx Pharma Llc, Univ Western Health Sciences filed Critical Tesorx Pharma Llc
Priority to JOP/2014/0322A priority Critical patent/JO3810B1/ar
Application granted granted Critical
Publication of JO3810B1 publication Critical patent/JO3810B1/ar

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

-<span dir="RTL">لقد تم دمج تركيبات التستوستيرون الجديدة التي الإفصاح عنها في نظام الشحيم الفسفوري/ الكولسترول لتنتج مسحوق البروليبوسومات للتشتت. كما يمكن صياغة مساحيق بروليبوسومال للتشتت وفقا للاختراع الحالي بسواغات مقبولة دوائيا لتشكل تركيبات دوائية. وتم الإفصاح عن أشكال جرعات تعطى بالفم تم تغطيتها بطبقة معوية كطرق المعالجة للعلاج ببدائل هرمون التستوستيرون. </span>
JOP/2014/0322A 2014-11-06 2014-11-06 صيغ التستوستيرون الشحمية المساندة JO3810B1 (ar)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2014/0322A JO3810B1 (ar) 2014-11-06 2014-11-06 صيغ التستوستيرون الشحمية المساندة

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2014/0322A JO3810B1 (ar) 2014-11-06 2014-11-06 صيغ التستوستيرون الشحمية المساندة

Publications (1)

Publication Number Publication Date
JO3810B1 true JO3810B1 (ar) 2021-01-31

Family

ID=75468979

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2014/0322A JO3810B1 (ar) 2014-11-06 2014-11-06 صيغ التستوستيرون الشحمية المساندة

Country Status (1)

Country Link
JO (1) JO3810B1 (ar)

Similar Documents

Publication Publication Date Title
PH12014502498A1 (en) Proliposomal testosterone formulations
MX2022004103A (es) Una formulacion de rapamicina inhalable para tratar afecciones relacionadas con la edad.
PH12017501057A1 (en) Substituted 2-anilinopyrimidine derivatives as egfr modulators
MX2022009155A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
EP3141603A4 (en) Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective
MD20170048A2 (ro) Formulare pe bază de acetat de abirateronă şi procedee de utilizare a acesteia
SG11201802983TA (en) Therapeutic compositions for treatment of human immunodeficiency virus
IN2014MU00303A (ar)
MX2017001103A (es) Derivados de indolizina que son aplicables a enfermedades neurodegenerativas.
ZA201703467B (en) Methods of treating ocular conditions
PT3142641T (pt) Formulações para o tratamento de hipertiroidismo
PH12017501694A1 (en) Compositions for the treatment of fibrosis and fibrosis-related diseases
JO3810B1 (ar) صيغ التستوستيرون الشحمية المساندة
IL252543B (en) Compounds for the treatment of degenerative retinal tissues
MA40444A (fr) Procédé de préparation de formulations de poudre sèche
TW201613563A (en) Bi-layer tablet formulations of cyclophosphamide and CAPECITABINE and highly fractionated METRONOMIC administration thereof
GEAP201814415A (en) Process for preparing the inhalation formulations
HK40016365A (en) Formulations for enteric delivery of therapeutic agents
HK40037113A (en) Process for generating therapeutic compositions of engineered cells
HK1262230A1 (en) Compositions and methods for delivery of therapeutic agents
MA40443A (fr) Nouveau procédé de préparation de formulations de poudre sèche
IN2014CH00269A (ar)